Sensei Biotherapeutics Inc (SNSE)
Market Open
12 Jun, 15:05
NASDAQ (CM) NASDAQ (CM) Primary $
11. 81
+1.02
+9.4532%
$
22.28M Market Cap
- P/E Ratio
- Div Yield
4,787 Volume
-1.01 Eps
$ 10.79
Previous Close Want to track SNSE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
What Makes Sensei Biotherapeutics (SNSE) a New Buy Stock
Sensei Biotherapeutics (SNSE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks | 1 year ago
Why Is Sensei Biotherapeutics (SNSE) Stock Down 40% Today?
Sensei Biotherapeutics (NASDAQ: SNSE ) stock is falling on Friday after it failed to impress investors with its latest Phase 1/2 clinical trial data for SNS-101. SNS-101 is a human monoclonal antibody targeting the immune checkpoint VISTA.
Investorplace | 2 years ago
